Skip to main content
. 2020 Oct 1;11:4931. doi: 10.1038/s41467-020-18708-x

Fig. 2. Crystal structure of MAGE-A11:PCF11 identifies MAGE substrate binding cleft.

Fig. 2

a MAGE-A11 directly interacts with PCF11 through its MHD. In vitro translated Myc-MAGE-A11 MHD, but not N-terminal fragment, binds to recombinant GST-PCF11. Source data are provided as a Source Data file. b Overall structure of human MAGE-A11 MHD with human PCF11 degron peptide. The alpha-helical PCF11 degron peptide binds into SBC at interface of WH-A and WH-B motifs of MAGE-A11 MHD. PCF11 peptide is shown in pink and MAGE-A11 in gray. c MAGE-A11 atoms within 5 Å of PCF11 are colored cyan to indicate the SBC region. Residues in the SBC that are mutated in this study are labeled and colored yellow. d Substrate interaction is largely achieved by hydrophobic interactions along the alpha-helical interface of PCF11 with MAGE-A11 SBC. e Myc-tagged MAGE-A11 wild-type or mutants were in vitro translated and followed by in vitro binding assay with recombinant GST-PCF11 637-702 amino acids, SDS-PAGE and immunoblotting for anti-Myc. Source data are provided as a Source Data file. f MAGE-A11 SBC is crucial for PCF11 substrate binding, but not HUWE1 E3 ligase binding, in cells. HEK293FT cells stably expressing FLAG-vector, FLAG-MAGE-A11 wild-type or mutants were subjected to pull-down with anti-FLAG followed by SDS-PAGE and immunoblotting for anti-HUWE1 and anti-PCF11. Source data are provided as a Source Data file. g TR-FRET binding assays of GST-MAGE-A11 with PCF11 peptide (FLVVVHQIRQLF*Q) containing phenylalanine (black circles), 3-methyl-phenylalanine (red triangles) or 4-cyano-phenylalanine (blue squares) at the indicated position (n = 2 biologically independent experiments with triplicates per peptide). Data are mean ± SD.